Speaker illustration

Doctor Jamol Uzokov

Republican Specialized Scientific-Practical Medical Center Therapy and Medical Rehabilitation, Tashkent (Uzbekistan)

Member of:

European Society of Cardiology
European Heart Rythm Association
Heart Failure Association

Does low glycemic index diet superior than routine diet to control blood inflammation state and lipid parameters in patients with coronary artery disease?

Event: ESC Congress 2022

Topic: Secondary Prevention

Session: Secondary prevention 2


Influence of diet with low glycemic index on anthropometric parameters in patients with atherosclerotic coronary artery disease

Event: ACNAP-EuroHeartCare 2022

Topic: Treatment

Session: ePoster session 3


Short-term outcomes of catheter ablation in atrial fibrillation in patients with metabolic syndrome

Event: EHRA 2022

Topic: Rhythm Control, Catheter Ablation

Session: ePosters Day 3


Clinical and angiographic characteristics and short-term outcomes of patients with non-ST elevation acute coronary syndrome with metabolic syndrome

Event: ESC Acute CardioVascular Care 2022

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: e-Posters session


Bilateral renal artery stenting is effective method for the treatment of uncontrolled hypertension and renal function

Event: ESC CONGRESS 2019

Topic: Device Treatment and Intervention

Session: Secondary hypertension and genes


Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Diabetes and the Heart

Session: Risk factors and prevention


Prognostic role of coronary artery calcium score in patients with metabolic syndrome

Event: ICNC 2019

Topic: Coronary Calcium

Session: Poster session II


Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome

Event: EuroPrevent 2018

Topic: Hypertension, Other

Session: Hypertension


Predictors of contrast induced nephropathy in patients with metabolic syndrome

Event: ESC CONGRESS 2017

Topic: PCI: procedural complications

Session: Primary and acute PCI


Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome


Topic: Drug therapy, other

Session: Drug therapy, other


ESC 365 is supported by

logo Novo Nordisk